Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

322
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
322
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in Depressive Symptoms Pre- and Post-Kidney Transplantation.

Kidney360·2026
Same author

Empowering Older Adults Through Values-Informed Solutions for Technology Adoption: Protocol for a Feasibility and Acceptability Randomized Controlled Pilot Trial.

JMIR research protocols·2026
Same author

Resilience: An Acquired Skill in Nephrology.

Advances in kidney disease and health·2026
Same author

Authors' Reply: Conceptual and Methodological Considerations in Assessing Disparities after Preemptive Kidney Transplant Waitlisting.

Journal of the American Society of Nephrology : JASN·2026
Same author

Chronic Psychologic Stress in Mice Induces Kidney Inflammation.

Kidney360·2026
Same author

Variation in Attitudes to Native Kidney Biopsy Practice in the United States.

Kidney medicine·2026

Related Experiment Video

Updated: Jun 27, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.2K

Sex Differences in Cardiovascular Outcomes in Patients With Kidney Failure.

Silvi Shah1, Annette L Christianson2, Karthikeyan Meganathan2

  • 1Division of Nephrology and Hypertension, Department of Internal Medicine University of Cincinnati Cincinnati OH USA.

Journal of the American Heart Association
|May 3, 2024
PubMed
Summary

Women undergoing dialysis face higher risks of heart failure and stroke but have lower mortality rates from cardiovascular causes and all-cause death compared to men. This highlights sex-based differences in cardiovascular outcomes for kidney failure patients.

Keywords:
cardiovascular eventsdeathdialysisdisparitiessex

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.5K
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

23.6K

Related Experiment Videos

Last Updated: Jun 27, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.2K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.5K
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

23.6K

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology
  • Sex-based medicine

Background:

  • Cardiovascular disease (CVD) is the primary cause of death in patients with kidney failure.
  • These patients exhibit a 10-20 fold increased risk of cardiovascular events compared to the general population.

Purpose of the Study:

  • To investigate sex-based differences in cardiovascular event risk, cardiovascular death, and all-cause mortality among patients initiating dialysis.
  • To analyze the association between sex and specific cardiovascular outcomes including acute coronary syndrome, heart failure, and stroke.

Main Methods:

  • Evaluation of 508,822 patients initiating dialysis between 2005 and 2014 using the United States Renal Data System (USRDS) with linked Medicare claims.
  • Determination of hospitalization rates for cardiovascular events (acute coronary syndrome, heart failure, stroke).
  • Utilized adjusted time-to-event models to examine the association of sex with outcomes.

Main Results:

  • Women comprised 44.7% of the study cohort (mean age 70±12 years).
  • The overall cardiovascular event rate was 232 per 1000 person-years, higher in women (248) than men (219).
  • Women demonstrated a 14% higher risk of cardiovascular events (HR 1.14), 16% higher risk of heart failure (HR 1.16), and 31% higher risk of stroke (HR 1.31), but no difference in acute coronary syndrome risk (HR 1.01).
  • Conversely, women had a lower risk of cardiovascular death (HR 0.89) and all-cause death (HR 0.96) compared to men.

Conclusions:

  • Among dialysis patients, women experience a greater risk of heart failure and stroke than men.
  • Despite higher event rates, women exhibit a lower adjusted risk for both cardiovascular mortality and all-cause mortality.
  • Findings underscore significant sex-based disparities in cardiovascular outcomes and mortality within the end-stage renal disease population.